{"pub": "fox", "title": "Johnson & Johnson's opioid verdict may benefit 2 other drugmakers", "url": "https://foxbusiness.com/healthcare/johnson-johnson-opioid-teva-pharmaceuticals-endo-international-stock", "language": "en", "published_at": "2019-08-27", "downloaded_at": "2019-09-02 06:59:01.424302+00:00", "text": "Drugmakers Teva Pharmaceuticals and Endo International are in focus Tuesday morning after an Oklahoma judge ordered Johnson & Johnson to pay $572 million in damages -- far less than what the state was seeking in its opioid lawsuit against the company. Both Teva and Endo are also being sued by Oklahoma for their alleged roles in the state\u2019s opioid crisis.\n\nContinue Reading Below\n\nAt 9:33 a.m. ET on Tuesday, Teva was trading up 0.8 percent and Endo was little changed.\n\nCleveland County District Judge Thad Balkman on Monday ruled the drugmaker was liable for contributing to the state\u2019s opioid crisis and ordered it to pay $572 million in damages. The state was seeking $17 billion. Johnson & Johnson, whose shares were up 1.33 percent early Tuesday, plans to appeal the verdict.\n\nCLICK HERE TO READ MORE ON FOX BUSINESS\n\nThe pharmaceutical industry has been hit with a number of opioid-related lawsuits over the past few years. OxyContin maker Purdue Pharma is being sued by 48 states, and a number of other opioid manufacturers are also facing lawsuits.", "description": "Teva Pharmaceuticals and Endo International are rallying after the Johnson & Johnson ruling.", "authors": [], "top_image": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2019/07/0/0/johnsonandjohnson.png?ve=1&tl=1"}